Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.26 - $0.87 $1,176 - $3,937
4,526 Added 526.28%
5,386 $1,000
Q2 2022

Oct 27, 2022

SELL
$0.68 - $1.87 $310 - $854
-457 Reduced 34.7%
860 $1,000
Q2 2022

Aug 15, 2022

SELL
$0.68 - $1.87 $310 - $854
-457 Reduced 34.7%
860 $1,000
Q1 2022

Oct 27, 2022

BUY
$1.58 - $8.47 $722 - $3,870
457 Added 53.14%
1,317 $2,000
Q1 2022

May 13, 2022

BUY
$1.58 - $8.47 $2,080 - $11,154
1,317 New
1,317 $2,000

About Baudax Bio, Inc.


  • Ticker BXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,003,700
  • Market Cap $200K
  • Description
  • Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuro...
More about BXRX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.